First drug approved for neurofibromas is a MEK inhibitor

被引：2

|

作者：

不详

机构：

来源：

NATURE BIOTECHNOLOGY | 2020年 / 38卷 / 05期

关键词：

D O I：

10.1038/s41587-020-0530-3

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：513 / 513

页数：1

相关论文

共 50 条

[1] First drug approved for neurofibromas is a MEK inhibitor
Nature Biotechnology, 2020, 38 : 513 - 513
[2] FDA approves MEK inhibitor for rare neurofibromas
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (04) : 238 - 238
[3] First RNAi drug approved
Cross, Ryan
CHEMICAL & ENGINEERING NEWS, 2018, 96 (33) : 5 - 5
[4] First deuterated drug approved
Schmidt, Charles
NATURE BIOTECHNOLOGY, 2017, 35 (06) : 493 - 494
[5] First Progeria Drug Is Approved
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 20 - 20
[6] First Smallpox Drug Approved
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (07): : 634 - 634
[7] First smallpox drug approved
Brainard, Jeffrey
SCIENCE, 2018, 361 (6399) : 208 - 208
[8] FIRST BIOSIMILAR DRUG APPROVED
不详
AMERICAN JOURNAL OF NURSING, 2015, 115 (07) : 24 - 24
[9] First deuterated drug approved
Charles Schmidt
Nature Biotechnology, 2017, 35 (6) : 493 - 494
[10] Treatment of Plexiform Neurofibromas with MEK Inhibitors: First Results with a New Therapeutic Option
Vaassen, Pia
Durr, Nikola Reinhard
Rosenbaum, Thorsten
NEUROPEDIATRICS, 2022, 53 (01) : 52 - 60

← 1 2 3 4 5 →